Skip to main content
Go to the home page of the European Commission (opens in new window)
English English
CORDIS - EU research results
CORDIS

A revolutionary digital therapeutics platform for personalized and effective neurocognitive rehabilitation

Project description

A digital revolution for patients with cognitive disorders

The number of people suffering from cognitive disorders is rapidly growing because of the ageing of the population and stressful lifestyles. Most cases of mild cognitive impairment can be treated, however, only 5 % of patients are successfully treated due to lack of efficient brain involvement during therapy. The EU-funded BE Therapy project will use digital technology to revolutionise the personalising effects of treatment. It will be based on personal wearable EEG devices for each patient and therapeutics platform. It will manage their data and autonomously adjust brain engagement practice to bring a maximum therapeutic effect. It will make the therapy more efficient, easier, cheaper and flexible.

Objective

Cognitive impairment causes decline in cognitive abilities, including memory and thinking skills. It is fast growing, and affects around 450 million people globally. The major causes of cognitive impairment are Traumatic Brain Injury (TBI), stroke, ageing, depression, anxiety and Attention-deficit/hyperactivity disorder (ADHD). Cognitive rehabilitation is a program to help brain-injured or otherwise cognitively impaired individuals to restore normal functioning, or to compensate for cognitive deficits. Nevertheless, the overall rehabilitation efficacy is surprisingly low (about 5%), even for patients with mild conditions. Multiple studies indicate that this stems from insufficient recruitment of patients’ brain engagement to the therapy.
BE Therapy is a revolutionary digital therapeutics platform for personalised and effective neurocognitive rehabilitation. It consists of a wearable EEG device and a patient management system. During cognitive therapy, BE Therapy proprietary algorithms capture real-time brain engagement from EEG data. The patient management platform then autonomously adjusts the therapy to be most effective to the patient, maximizing brain engagement and dramatically improving cognitive therapy efficacy. This personalisation can be tweaked or supervised by an onsite or remote physician. Digitisation of the platform enables to optimise session frequencies and increase availability to serve more patients, thus maximising public health care system resources. Being a home-point-of-care solution, it reduces the costs and time associated with the rehabilitation.
During the phase 1 feasibility study, Brainmarc will establish a sound go-to-market strategy and supply chain, and will outline further development plans. In the second phase of the innovation project, Brainmarc will optimize the device and treatment management system, perform clinical validation with European hospitals and rehabilitation centers, and obtain CE mark for market entry.

Fields of science (EuroSciVoc)

CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.

You need to log in or register to use this function

Programme(s)

Multi-annual funding programmes that define the EU’s priorities for research and innovation.

Topic(s)

Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.

Funding Scheme

Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.

SME-1 - SME instrument phase 1

See all projects funded under this funding scheme

Call for proposal

Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.

(opens in new window) H2020-EIC-SMEInst-2018-2020

See all projects funded under this call

Coordinator

BRAINMARC LTD
Net EU contribution

Net EU financial contribution. The sum of money that the participant receives, deducted by the EU contribution to its linked third party. It considers the distribution of the EU financial contribution between direct beneficiaries of the project and other types of participants, like third-party participants.

€ 50 000,00
Address
TAVOR BUILDING 2ND ENTRANCE 3RD FLOOR
2069200 YOKNEAM
Israel

See on map

SME

The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.

Yes
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Links
Total cost

The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.

€ 71 429,00
My booklet 0 0